(Q43234808)

English

Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure

scientific article published on 26 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Hope D. Anderson

8

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

author name string

Sijo J Thandapilly

1

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Peter Wojciechowski

2

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

John Behbahani

3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Xavier L Louis

4

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Liping Yu

5

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Danijel Juric

6

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Melanie A Kopilas

7

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Thomas Netticadan

9

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

publication date

26 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

192-196

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Tackling heart failure in the twenty-first century

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

Heart failure: targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

Controversies in ventricular remodelling

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

Chronic intake of a phytochemical-enriched diet reduces cardiac fibrosis and diastolic dysfunction caused by prolonged salt-sensitive hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

Novel effects of a single administration of ferulic acid on the regulation of blood pressure and the hepatic lipid metabolic profile in stroke-prone spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

Studies of prevention, treatment and mechanisms of heart failure in the aging spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

Is cardiac hypertrophy in spontaneously hypertensive rats the cause or the consequence of oxidative stress?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

21 January 2018

Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Similarities of genetic (spontaneous) hypertension. Man and rat.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Rat models of hypertension, cardiac hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Noninvasive evaluation of the time course of change in cardiac function in spontaneously hypertensive rats by echocardiography

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Resveratrol ameliorates experimental autoimmune myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.228

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/AJH.2009.228

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43234808&oldid=2093900649"